litlas
Log inCreate account

Gary L. Johnson

Active 1978–2025

169
Papers
38,229
Citations
105
h-index
167
i10-index

Citations

Citations per year for Gary L. Johnson1965: 1 citations1978: 3 citations1979: 12 citations1980: 30 citations1981: 22 citations1982: 23 citations1983: 18 citations1984: 18 citations1985: 28 citations1986: 23 citations1987: 18 citations1988: 19 citations1989: 24 citations1990: 35 citations1991: 47 citations1992: 77 citations1993: 120 citations1994: 287 citations1995: 476 citations1996: 521 citations1997: 529 citations1998: 627 citations1999: 684 citations2000: 649 citations2001: 638 citations2002: 559 citations2003: 552 citations2004: 552 citations2005: 375 citations2006: 414 citations2007: 352 citations2008: 272 citations2009: 264 citations2010: 272 citations2011: 221 citations2012: 246 citations2013: 261 citations2014: 215 citations2015: 201 citations2016: 168 citations2017: 151 citations2018: 189 citations2019: 625 citations2020: 659 citations2021: 595 citations2022: 463 citations2023: 321 citations2024: 460 citations2025: 166 citations2026: 9 citations1966–1977: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,496 citing papers, 39.9% of this breakdownChina: 1,253 citing papers, 9.1% of this breakdownUnited Kingdom: 820 citing papers, 6% of this breakdownGermany: 711 citing papers, 5.2% of this breakdownJapan: 654 citing papers, 4.8% of this breakdownCanada: 530 citing papers, 3.8% of this breakdownFrance: 446 citing papers, 3.2% of this breakdownItaly: 334 citing papers, 2.4% of this breakdownSouth Korea: 302 citing papers, 2.2% of this breakdownSpain: 229 citing papers, 1.7% of this breakdownAustralia: 225 citing papers, 1.6% of this breakdownSwitzerland: 223 citing papers, 1.6% of this breakdown
0%39.9%Other 18.5%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology54.4%
  • Medicine26.9%
  • Immunology and Microbiology7.4%
  • Neuroscience4.2%
  • Agricultural and Biological Sciences2%
  • Computer Science1.3%
  • Other3.8%

Topics

  • Protein Kinase Regulation and GTPase Signaling5%
  • Melanoma and MAPK Pathways4.4%
  • Cell death mechanisms and regulation2.4%
  • NF-κB Signaling Pathways2.2%
  • Cellular Mechanics and Interactions1.8%
  • Receptor Mechanisms and Signaling1.7%
  • Other82.5%

Coauthors

All papers

Open in search
  1. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases

    Authors: Gary L. Johnson, Razvan Lapadat - Science 2002 cited by 4,312

  2. Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human

    Authors: Christian Widmann, Spencer B. Gibson, Matthew Jarpe, Gary L. Johnson - Physiological Reviews 1999 cited by 2,752

  3. Unexplored therapeutic opportunities in the human genome

    Authors: Tudor I. Oprea, Cristian Bologa, Søren Brunak, Allen Campbell, Gregory N. Gan, Anna Gaulton, Shawn M. Gomez, Rajarshi Guha, Anne Hersey, Jayme Holmes, Ajit Jadhav, Lars Juhl Jensen, Gary L. Johnson, Anneli Karlson, Andrew R. Leach, Avi Ma’ayan, Anna Malovannaya, Subramani Mani, Stephen L. Mathias, Michael T. McManus, Terrence F. Meehan, Christian von Mering, Daniel Muthas, Ðắc-Trung Nguyễn, John P. Overington, George Papadatos, Jun Qin, Christian Reich, Bryan L. Roth, Stephan C. Schürer, Anton Simeonov, Larry A. Sklar, Noel Southall, Susumu Tomita, Ilinca Tudose, Oleg Ursu, D. Vidović, Anna Waller, David Westergaard, Jeremy J. Yang, Gergely Zahoránszky-Köhalmi - Nature Reviews Drug Discovery 2018 cited by 385

  4. Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer

    Authors: James S. Duncan, Martin C. Whittle, Kazuhiro Nakamura, Amy N. Abell, Alicia A. Midland, Jon S. Zawistowski, Nancy L. Johnson, Deborah A. Granger, Nicole Vincent Jordan, David B. Darr, Jerry Usary, Pei Fen Kuan, David M. Smalley, Ben Major, Xiaping He, Katherine A. Hoadley, Bing Zhou, Norman E. Sharpless, Charles M. Perou, William Y. Kim, Shawn M. Gomez, Xin Chen, Jian Jin, Stephen V. Frye, H. Shelton Earp, Lee M. Graves, Gary L. Johnson - Cell 2012 cited by 750

  5. The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease

    Authors: Gary L. Johnson, Kazuhiro Nakamura - Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2007 cited by 498

  6. Coordination of Rho GTPase activities during cell protrusion

    Authors: Matthias Macháček, Louis Hodgson, Christopher M. Welch, Hunter Elliott, Olivier Pertz, Perihan Nalbant, Amy N. Abell, Gary L. Johnson, Klaus M. Hahn, Gaudenz Danuser - Nature 2009 cited by 1,016

  7. Erratum: Unexplored therapeutic opportunities in the human genome

    Authors: Tudor I. Oprea, Cristian Bologa, Søren Brunak, Allen Campbell, Gregory N. Gan, Anna Gaulton, Shawn M. Gomez, Rajarshi Guha, Anne Hersey, Jayme Holmes, Ajit Jadhav, Lars Juhl Jensen, Gary L. Johnson, Anneli Karlson, Andrew R. Leach, Avi Ma’ayan, Anna Malovannaya, Subramani Mani, Steven L. Mathias, Michael T. McManus, Terrence F. Meehan, Christian von Mering, Daniel Muthas, Ðắc-Trung Nguyễn, John P. Overington, George Papadatos, Jun Qin, Christian Reich, Bryan L. Roth, Stephan C. Schürer, Anton Simeonov, Larry A. Sklar, Noel Southall, Susumu Tomita, Ilinca Tudose, Oleg Ursu, D. Vidović, Anna Waller, David Westergaard, Jeremy J. Yang, Gergely Zahoránszky-Köhalmi - Nature Reviews Drug Discovery 2018 cited by 323

  8. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

    Authors: Susana García‐Recio, Aatish Thennavan, Michael P. East, Joel S. Parker, Juan Miguel Cejalvo, Joseph P. Garay, Daniel P. Hollern, Xiaping He, Kevin R. Mott, Patricia Galván, Cheng Fan, Sara R. Selitsky, Alisha R. Coffey, David Marron, Fara Brasó‐Maristany, Octavio Burgués, Joan Albanell, Federico Rojo, Aňa Lluch, Eduardo Martínez de Dueñas, Jeffery M. Rosen, Gary L. Johnson, Lisa A. Carey, Aleix Prat, Charles M. Perou - Journal of Clinical Investigation 2020 cited by 110

  9. Mixed-lineage kinase control of JNK and p38 MAPK pathways

    Authors: Kathleen A. Gallo, Gary L. Johnson - Nature Reviews Molecular Cell Biology 2002 cited by 578

  10. Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex

    Authors: Jon S. Zawistowski, Samantha M. Bevill, Daniel R. Goulet, Timothy J. Stuhlmiller, Adriana S. Beltrán, José F. Olivares-Quintero, Darshan Singh, Noah Sciaky, Joel S. Parker, Naim U. Rashid, Xin Chen, James S. Duncan, Martin C. Whittle, Steven P. Angus, Sara H. Velarde, Brian T. Golitz, Xiaping He, Charlene Santos, David B. Darr, Kristalyn K. Gallagher, Lee M. Graves, Charles M. Perou, Lisa A. Carey, H. Shelton Earp, Gary L. Johnson - Cancer Discovery 2017 cited by 185

  11. Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

    Authors: Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp - Nature Medicine 2021 cited by 96

  12. Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains

    Authors: Timothy J. Stuhlmiller, Samantha M. Miller, Jon S. Zawistowski, Kazuhiro Nakamura, Adriana S. Beltrán, James S. Duncan, Steven P. Angus, Kyla Collins, Deborah A. Granger, Rachel A. Reuther, Lee M. Graves, Shawn M. Gomez, Pei Fen Kuan, Peter J. Park, Xin Chen, Noah Sciaky, Lisa A. Carey, H. Shelton Earp, Jian Jin, Gary L. Johnson - Cell Reports 2015 cited by 281

  13. New strategies for targeting kinase networks in cancer

    Authors: Ali E. Yesilkanal, Gary L. Johnson, Alexandre F. Ramos, Marsha Rich Rosner - Journal of Biological Chemistry 2021 cited by 55

  14. Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted Inhibition of the BRAF–MEK–ERK Pathway in Cancer

    Authors: Gary L. Johnson, Timothy J. Stuhlmiller, Steven P. Angus, Jon S. Zawistowski, Lee M. Graves - Clinical Cancer Research 2014 cited by 125

  15. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation

    Authors: Daniel R. Ambruso, Cindy Knall, Amy N. Abell, Julie A. Panepinto, Arlet G. Kurkchubasche, Gail Thurman, Carolina Gonzalez-Aller, Andrew Hiester, Martin deBoer, Ronald J. Harbeck, Ryan Oyer, Gary L. Johnson, Dirk Roos - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 480

  16. Role of mitogen-activated protein kinase kinase kinases in signal integration

    Authors: Bruce D. Cuevas, Amy N. Abell, Gary L. Johnson - Oncogene 2007 cited by 289

  17. Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases

    Authors: Cindy Knall, G. Scott Worthen, Gary L. Johnson - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 323

  18. Rac–MEKK3–MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock

    Authors: Mark Uhlik, Amy N. Abell, Nancy L. Johnson, Weiyong Sun, Bruce D. Cuevas, Katherine E. Lobel-Rice, Eric A. Horne, Mark L. Dell’Acqua, Gary L. Johnson - Nature Cell Biology 2003 cited by 380

  19. Interleukin-8 Regulation of the Ras/Raf/Mitogen-activated Protein Kinase Pathway in Human Neutrophils

    Authors: Cindy Knall, Scott K. Young, Jerry A. Nick, Anne Mette Buhl, G. Scott Worthen, Gary L. Johnson - Journal of Biological Chemistry 1996 cited by 244

  20. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer

    Authors: Nicole Vincent Jordan, Gary L. Johnson, Amy N. Abell - Cell Cycle 2011 cited by 216

  21. Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype

    Authors: Asya L. Borikova, Christopher F. Dibble, Noah Sciaky, Christopher M. Welch, Amy N. Abell, Sompop Bencharit, Gary L. Johnson - Journal of Biological Chemistry 2010 cited by 142

  22. MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis

    Authors: Thu Thuy Pham, Steven P. Angus, Gary L. Johnson - Genes & Cancer 2013 cited by 134

  23. MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells

    Authors: Amy N. Abell, Nicole Vincent Jordan, Weichun Huang, Aleix Prat, Alicia A. Midland, Nancy L. Johnson, Deborah A. Granger, Piotr A. Mieczkowski, Charles M. Perou, Shawn M. Gomez, Leping Li, Gary L. Johnson - Cell stem cell 2011 cited by 129

  24. PB1 Domain Interaction of p62/Sequestosome 1 and MEKK3 Regulates NF-κB Activation

    Authors: Kazuhiro Nakamura, Adam J. Kimple, David P. Siderovski, Gary L. Johnson - Journal of Biological Chemistry 2009 cited by 128